Wilson Sonsini Goodrich & Rosati advised Recursion on the deal. Recursion, a clinical-stage biotechnology company decoding biology to radically improve lives by industrializing drug discovery, development,...
Recursion’s Collaboration with Roche and Genentech
DoorDash’s €7 Billion Acquisition of Wolt
Wilson Sonsini Goodrich & Rosati, Allen & Overy, Avance Attorneys, Bech-Bruun, BDK Advokati and Erdinast, Ben Nathan, Toledano & Co. represented DoorDash, while Skadden, Arps, Slate,...
Mitel Networks’ Partnership With RingCentral
Wilson Sonsini Goodrich & Rosati advised RingCentral, while Wachtell, Lipton, Rosen & Katz advised Searchlight and MLN TopCo Limited, the parent of Mitel. Mitel Networks, Inc.,...
Metagenomi’s Collaboration with Moderna
Fenwick & West and Wilson Sonsini Goodrich & Rosati represented Metagenomi on the deal. Metagenomi, Inc., a genetic medicines company with a versatile portfolio of next-generation...
Zendesk Inc.’s Acquisition of Momentive
Hogan Lovells advised Zendesk on the deal. Latham & Watkins represented JP Morgan, financial advisor to Momentive. Wilson Sonsini advised Momentive. Zendesk (NYSE: ZEN) and Momentive (NASDAQ:...
Synthekine’s Collaboration and License Agreement with Merck
Wilson Sonsini Goodrich & Rosati advised Synthekine on the deal. Synthekine Inc., an engineered cytokine therapeutics company, announced that it has entered into a worldwide research...
Udemy’s Initial Public Offering
Wilson Sonsini Goodrich & Rosati advised Udemy on the deal, while Simpson Thacher represented the underwriters. Udemy announced the pricing of its initial public offering of...
Ambarella’s Acquisition of Oculii
Wilson Sonsini Goodrich & Rosati advised Ambarella on the deal. Ambarella, an AI vision silicon company, announced it has entered into a definitive agreement to acquire...
Arcaea’s $78 Million Series A Financing
Wilson Sonsini Goodrich & Rosati advised Arcaea on the deal. Arcaea, a company launched on the Ginkgo Bioworks platform, announced its $78 million Series A to...
Roblox’s Senior Notes Offering
Wilson Sonsini Goodrich & Rosati advised Roblox on the deal. Simpson Thacher represented Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC and J.P. Morgan...
Ventyx’s $174 Million IPO
Wilson Sonsini Goodrich & Rosati advised Ventyx on the deal. Ventyx Biosciences, a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living...
Quanta Therapeutics’ $60 Million Series C Financing Round
Wilson Sonsini Goodrich & Rosati advised Quanta Therapeutics on the deal. Quanta Therapeutics, Inc., a privately held biopharmaceutical company pioneering complex-directed therapies to treat RAS-driven cancer...